Amyotrophic Lateral Sclerosis Current Events | Amyotrophic Lateral Sclerosis News | 4
|
| Page
4 of
15 |
296 Results |
|
|
|
Sort By:
Page Views | Date |
3-substituted indolones as novel therapeutic compounds for neurodegenerative conditions
Neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS), disrupt the quality of life for patients, put a tremendous burden on family caregivers, and cost society billions of dollars annually. view more (2008-10-29)
Study finds a high caloric diet may prevent the progression of amyotrophic lateral sclerosis
A recent study directed by the Mount Sinai School of Medicine suggests a ketogenic- high caloric diet may prevent the progression of Amyotrophic Lateral Sclerosis (ALS). view more (2006-04-18)
Vitamin B3 reduces Alzheimer's symptoms, lesions
An over-the-counter vitamin in high doses prevented memory loss in mice with Alzheimer's disease, and UC Irvine scientists now are conducting a clinical trial to determine its effect in humans. view more (2008-11-05)
New research shows sharks use their noses and bodies to locate smells
Sharks are known to have a keen sense of smell, which in many species is critical for finding food. However, according to new research from Boston University marine biologists, sharks can not use just their noses to locate prey; they also need their skin - specifically a location called the lateral line. view more (2007-05-30)
New Jefferson study may redefine how a chronic auto-immune disease is diagnosed
New research from Jefferson Hospital for Neuroscience (JHN) may redefine how Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is diagnosed. view more (2009-06-11)
Downstate researchers target multiple sclerosis
Researchers at SUNY Downstate Medical Center have developed a substance that inhibits the progress of multiple sclerosis (MS) in an animal model. The agent, a novel calpain inhibitor, can be administered orally. view more (2006-11-22)
Lords Call For Faster Progress Towards Cannabis-Based Medicine
Progress towards a cannabis-based medicine for conditions such as multiple sclerosis is too slow, says the House of Lords Science & Technology Committee in a report published today [22 March]. The use of cannabis for any purpose other than scientific research is currently illegal. In November 1998 the Lords Committee recommended, on the basis... view more... (2001-03-22)
Essential Hope for Multiple Sclerosis
New research by psychologists reveals the positive effects of aromatherapy on the quality of life for Multiple Sclerosis (MS) sufferers. Researchers at the University of Teeside found MS patients, in spite of experiencing the same symptoms, felt more vitality, happiness and peace during aromatherapy treatment, and less depression, fatigue and... view more... (2004-08-23)
Umbilical cord blood cell transplants may help ALS patients
A study at the University of South Florida has shown that transplants of mononuclear human umbilical cord blood (MNChUCB) cells may help patients suffering from Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease. view more (2008-06-25)
U of MN researchers identify ataxia gene
Researchers at the University of Minnesota Medical School have discovered the gene responsible for a type of ataxia, an incurable degenerative brain disease affecting movement and coordination. view more (2006-01-23)
Spinal fluid proteins signal Lou Gehrig's disease
High levels of certain proteins in the spinal fluid could signal the onset of Lou Gehrig's disease, according to researchers. The discovery of these biomarkers may lead to diagnostic kits for early diagnosis, accurately measuring the progression of the disease and monitoring the effects of treatment. view more (2009-01-29)
Protein aggregates in Lou Gehrig's disease linked to neuron death
French neurologist Jean-Martin Charcot first described amyotrophic lateral sclerosis (ALS) in 1869, but, nearly 140 years later, little is known about the cause of the devastating neurodegenerative disease, and there is no cure view more (2005-10-27)
Gene hunters close in on Lou Gehrig's disease
In the first genome-wide search for the genetic roots of the most common form of amyotrophic lateral sclerosis (ALS), Johns Hopkins scientists have newly identified 34 unique variations in the human genetic code among 276 unrelated subjects with ALS. view more (2007-02-21)
First international gene screen for typical ALS is on track
The largest-scale search for genes that underlie sporadic amyotrophic lateral sclerosis (ALS), the most common form of the disease, has crossed its first hurdle with the successful compiling of genetic information on more than 1,000 patients and controls. view more (2006-11-29)
Serum carcinoembryonic antigen level can reflect adrenal adenoma
The female patient, reported on the December 7 issue 45 of World J Gastroenterology, presented a rare case, with symptoms consistent with hyperadrenocorticism and hypercatecholaminism, and also had a Cushingoid appearance. view more (2007-11-26)
Protein plays Jekyll and Hyde role in Lou Gehrig's disease
Amyotrophic lateral sclerosis (ALS), more commonly known as Lou Gehrig's disease, is a fatal neurodegenerative disease caused by the death of motor neurons in the brain and spinal cord that control muscle movements from walking and swallowing to breathing. In a groundbreaking study this week in PLoS Biology, Brandeis and Harvard Medical School... view more... (2008-07-29)
Penn researchers find potential in yeast for selecting Lou Gehrig's disease drugs
Researchers from the University of Pennsylvania School of Medicine are developing a novel approach to screen for drugs to combat neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, using yeast cells. view more (2008-04-18)
Scientists design simple dipstick test for cocaine, other drugs
Researchers at the University of Illinois at Urbana-Champaign have developed a simple "dipstick" test for detecting cocaine and other drugs in saliva, urine or blood serum. view more (2006-11-14)
Milestone for cannabinoid MS study
The CUPID (Cannabinoid Use in Progressive Inflammatory brain Disease) study at the Peninsula Medical School in Plymouth has reached an important milestone with the news that the full cohort of 493 people with multiple sclerosis (MS) has been recruited to the study. view more (2008-07-22)
Discovery of agile molecular motors could aid in treating motor neuron diseases
Over the last several months, the labs of Yale Goldman, MD, PhD, Director of the Pennsylvania Muscle Institute at the University of Pennsylvania School of Medicine, and Erika Holzbaur, PhD, Professor of Physiology, have published a group of papers that, taken together, show proteins that function as molecular motors are surprisingly flexible and... view more... (2006-07-18)
|
|
| Page
4 of
15 |
296 Results |
|
|
|
Sort By:
Page Views | Date |
|
